All In MedTech

Device Trial Radar · NCT07103057

VIZ ACCESS HCM - Multi-Site Registry

ACCESS HCM: Real World Evidence for Artificial-Intelligence-assisted Screening and Access to Care for HCM - A Multi-Site Registry

Last checked: Nov 20, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

17

Actual

Start

Jun 13, 2025

Primary completion

Sep 17, 2026

Study completion Sep 17, 2026

Sponsor

Lead sponsor
Viz.ai, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 5, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.

Conditions

  • Hypertrophic Cardiomyopathy

Interventions

  • Viz HCMDevice

    Viz HCM is a Software as a Medical Device (SaMD) intended to receive 12-lead ECG recordings collected as part of a routine clinical assessment and analyze them in parallel to the standard of care. The device uses a machine learning based algorithm to analyze 12-lead ECGs and identify ECGs with suspected HCM.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical characteristics of Viz HCM AI screening on HCM diagnosisTime frame: Up to 3 years
  2. Clinical characteristics of Viz HCM AI screening on medical workup.Time frame: Up to 3 years
  3. Clinical characteristics of Viz HCM AI screening on treatment plans.Time frame: Up to 3 years

7 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Emory University

    Atlanta, Georgia

  • North Shore University Health System

    Evanston, Illinois

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.